{
    "clinical_study": {
        "@rank": "142892", 
        "acronym": "TOCAT", 
        "arm_group": [
            {
                "arm_group_label": "Oral mixed tocotrienols", 
                "arm_group_type": "Experimental", 
                "description": "2 capsules containing 100mg mixed tocotrienols per capsule taken orally once a day for 6 months"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "2 capsules containing soya bean oil taken orally once a day for 6 months"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine if tocotrienol supplementation given to school\n      going children with ADHD will result in reduction of their ADHD symptoms."
        }, 
        "brief_title": "Tocotrienols for School-going Children With ADHD", 
        "completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "condition": "Attention Deficit Disorder With Hyperactivity", 
        "condition_browse": {
            "mesh_term": [
                "Attention Deficit Disorder with Hyperactivity", 
                "Hyperkinesis"
            ]
        }, 
        "detailed_description": {
            "textblock": "The main objective of the study is to:\n\n      a. Determine if supplementation of tocotrienol compared to placebo has an effect on the\n      symptoms of school going children with ADHD.\n\n      The secondary objective is to:\n\n        1. Determine if supplementation of tocotrienol compared to placebo has an effect on the\n           dose of current medication used in school going children with ADHD.\n\n        2. Determine the safety of tocotrienol in the study population.\n\n        3. Determine if tocotrienol levels in children with ADHD correlate with their symptom\n           scores."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosed with ADHD in accordance with the Diagnostic and Statistical Manual (DSM) IV\n             criteria.\n\n          -  Be able to swallow soft gel capsules.\n\n          -  If already on medication for ADHD, the dose of the medication must be stable for the\n             last 3months\n\n          -  Be able to attend all follow up visits.\n\n          -  Be agreeable to have their teacher score the National Initiative for Children's\n             Healthcare Quality (NICHQ) Vanderbilt Assessment Scale - Teacher Informant\n\n          -  Be willing to have their blood taken 3 times during the study.\n\n        Exclusion Criteria:\n\n          -  ADHD caused by syndromes, inborn errors of metabolism, or structural brain lesions.\n\n          -  Co-existing chronic liver disease\n\n          -  Current use of anticoagulant or antiplatelet drugs."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "12 Years", 
            "minimum_age": "6 Years"
        }, 
        "enrollment": {
            "#text": "160", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01855984", 
            "org_study_id": "NMRR-6767"
        }, 
        "intervention": [
            {
                "arm_group_label": "Oral mixed tocotrienols", 
                "description": "200mg per day", 
                "intervention_name": "Oral mixed tocotrienols", 
                "intervention_type": "Dietary Supplement", 
                "other_name": "Tocovid Suprabio."
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "Capsules containing soya bean oil that has similar appearance with the mixed tocotrienol capsules", 
                "intervention_name": "Placebo", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Tocotrienols", 
                "Vitamin E", 
                "Tocopherols"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "ADHD", 
            "Children", 
            "Tocotrienol"
        ], 
        "lastchanged_date": "June 13, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Georgetown", 
                    "country": "Malaysia", 
                    "state": "Penang", 
                    "zip": "10990"
                }, 
                "name": "Child & Adolescent Psychiatry Unit, Hospital Pulau Pinang"
            }
        }, 
        "location_countries": {
            "country": "Malaysia"
        }, 
        "number_of_arms": "2", 
        "official_title": "Tocotrienols Supplementation in School Going Children With Attention Deficit/Hyperactivity Disorder(ADHD) - A Randomized Controlled Trial", 
        "overall_official": {
            "affiliation": "Penang Medical College", 
            "last_name": "May Loong Tan, MRCPCH(UK)", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Malaysia: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "ADHD symptom scores as measured by NICHQ Vanderbilt Parent and Teacher Assessment Scales", 
            "safety_issue": "No", 
            "time_frame": "Change of total symptom scores from baseline at 6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01855984"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Penang Medical College", 
            "investigator_full_name": "May Loong Tan", 
            "investigator_title": "Dr", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change in the dose of current medication for ADHD", 
                "safety_issue": "No", 
                "time_frame": "After 6 months intervention"
            }, 
            {
                "measure": "Number of participants with adverse reaction", 
                "safety_issue": "Yes", 
                "time_frame": "6 months"
            }, 
            {
                "measure": "Blood tocotrienol levels", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }
        ], 
        "source": "Penang Medical College", 
        "sponsors": {
            "collaborator": {
                "agency": "Penang Hospital, Malaysia", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Penang Medical College", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}